Cargando…

The Future of Luteal Phase Support in ART and the Role of Dydrogesterone

Detalles Bibliográficos
Autores principales:	Drakopoulos, Panagiotis, Roelens, Caroline, De Vos, Michel, Mackens, Shari, Racca, AnnaLisa, Tournaye, Herman, Blockeel, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Reproductive Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580764/ https://www.ncbi.nlm.nih.gov/pubmed/36304706 http://dx.doi.org/10.3389/frph.2020.618838

Ejemplares similares

Luteal Phase Support in IVF: Comparison Between Evidence-Based Medicine and Real-Life Practices
por: Di Guardo, Federica, et al.
Publicado: (2020)

To delay or not frozen embryo transfer in freeze-all cycles?
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
por: Griesinger, Georg, et al.
Publicado: (2018)

Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
por: Mackens, Shari, et al.
Publicado: (2020)

Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates
por: Romito, Alessia, et al.
Publicado: (2020)

Endometrial receptivity enhancement through induced injury and repair during ovarian stimulation: the Receptivity Enhancement by Follicular-phase Renewal after Endometrial ScratcHing (REFRESH) trial protocol
por: Santos-Ribeiro, Samuel, et al.
Publicado: (2017)

Corrigendum: Endometrial receptivity enhancement through induced injury and repair during ovarian stimulation: the Receptivity Enhancement by Follicular-phase Renewal after Endometrial ScratcHing (REFRESH) trial protocol
por: Santos-Ribeiro, Samuel, et al.
Publicado: (2020)

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization
por: Tournaye, Herman, et al.
Publicado: (2017)

Clinical pregnancy rate for frozen embryo transfer with HRT: a randomized controlled pilot study comparing 1 week versus 2 weeks of oestradiol priming
por: Racca, Annalisa, et al.
Publicado: (2023)

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders
por: Errázuriz, Joaquín, et al.
Publicado: (2019)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

Type and dose of gonadotropins in poor ovarian responders: does it matter?
por: Boudry, Liese, et al.
Publicado: (2021)

Poor ovarian response and the possible role of natural and modified natural cycles
por: Di Guardo, Federica, et al.
Publicado: (2022)

Editorial: Luteal Phase Support for Assisted Reproduction
por: Friedler, Shevach, et al.
Publicado: (2021)

Luteal phase support in fresh and frozen embryo transfers
por: Greenbaum, Shirley, et al.
Publicado: (2022)

The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review
por: Muneeba, Shaikh, et al.
Publicado: (2023)

Comparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial
por: Khosravi, Donya, et al.
Publicado: (2015)

Luteal Phase Support Using Subcutaneous Progesterone: A Systematic Review
por: Conforti, Alessandro, et al.
Publicado: (2021)

Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny
por: Jeschke, Laura, et al.
Publicado: (2021)

Low Testosterone and Semen Parameters in Male Partners of Infertile Couples Undergoing IVF with a Total Sperm Count Greater than 5 Million
por: Di Guardo, Federica, et al.
Publicado: (2020)

Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis
por: Peng, Chao, et al.
Publicado: (2021)

Luteal Phase in Assisted Reproductive Technology
por: Tesarik, Jan, et al.
Publicado: (2020)

A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in In vitro Fertilization: A Randomized Controlled Trial
por: Naghshineh, Elham, et al.
Publicado: (2023)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial
por: Salehpour, Saghar, et al.
Publicado: (2013)

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone
por: Vidal, Angela, et al.
Publicado: (2023)

When Can We Safely Stop Luteal Phase Support in Fresh IVF Cycles? A Literature Review
por: Mizrachi, Yossi, et al.
Publicado: (2020)

The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation
por: Drakopoulos, Panagiotis, et al.
Publicado: (2018)

A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles
por: Ikechebelu, Joseph Ifeanyichukwu, et al.
Publicado: (2023)

Corifollitropin α followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of a multicentre randomised trial
por: Polyzos, Nikolaos P, et al.
Publicado: (2013)

Gonadotropin Dependent Neuregulin1 Signaling Regulates Luteal Cell Survival
por: Jones, Jennifer, et al.
Publicado: (2021)

Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis
por: Barbosa, Marina Wanderley Paes, et al.
Publicado: (2018)

Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
por: Simon, Virginie, et al.
Publicado: (2022)

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023)

Inhibition of Delta-Like Ligand 4 Induces Luteal Hypervascularization Followed by Functional and Structural Luteolysis in the Primate Ovary
por: Fraser, Hamish M., et al.
Publicado: (2012)

OR31-05 Emergence of Ovarian Hyperandrogenism and Luteal Insufficiency Following ESR1 Knockdown in the Mediobasal Hypothalamus of Adult Female Rhesus Monkeys
por: Levine, Jon E, et al.
Publicado: (2020)

OR06-4 Women With Obesity Display Defects in Follicular Recruitment, Selection, and Dominance Alongside Luteal Phase Dysfunction During Natural Ovulatory Cycles
por: Carter, Faith, et al.
Publicado: (2022)

SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts
por: Essahib, Wafaa, et al.
Publicado: (2020)

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
por: Drakopoulos, Panagiotis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n8g7ien6djm0rhb1lfntdba10f